Health at a Glance 2015
OECD Indicators
This new edition of Health at a Glance presents the most recent comparable data on the performance of health systems in OECD countries. Where possible, it also reports data for partner countries (Brazil, China, Colombia, Costa Rica, India, Indonesia, Latvia, Lithuania, Russian Federation and South Africa). Compared with the previous edition, this new edition includes a new set of dashboards of health indicators to summarise in a clear and user-friendly way the relative strengths and weaknesses of OECD countries on different key indicators of health and health system performance, and also a special focus on the pharmaceutical sector. This edition also contains new indicators on health workforce migration and on the quality of health care.
Pharmaceutical expenditure
Pharmaceuticals play a vital role in the health system and policy makers must balance the access of patients to new effective medicines with limited health care budgets, while providing the right incentives to manufacturers to develop new generations of drugs. After inpatient and outpatient care, pharmaceuticals represent the third largest expenditure item of health care spending and accounted for more than a sixth (17%) of health expenditure on average across OECD countries in 2013, not taking into account spending on pharmaceuticals in hospitals.
Also available in: French
- Click to access:
-
Click to download PDF - 259.79KBPDF
-
Click to Read online and shareREAD